Skip to content
drillr.ai

STVN

Stevanato Group S.p.A.

NYSE · ITHealthcareMedical - Instruments & Supplies
$19.15-0.10%

Price as of Jul 20, 2026

STVN news

Stevanato Group S.p.A. news

A server-rendered, paginated timeline of the latest available company news.

  1. Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

    Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management The fixed-dose, multi-use pen injector platform features a pull-push mechanism designed to reduce use error while supporting delivery volumes up to 0.75 mL Stevanato Group S.p.A. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.stevanatogroup.com&esheet=54548150&newsitemid=20260608096966&lan=en-US&anchor=Stevanato+Group+S.p.A.&index=1&md5=bbd6af27f7309d0f5f7dd52354

    Business Wire ·

  2. Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting

    Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting All Resolutions Proposed to Shareholders Passed Stevanato Group S.p.A. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.stevanatogroup.com&esheet=54547054&newsitemid=20260603221961&lan=en-US&anchor=Stevanato+Group+S.p.A.&index=1&md5=b6702ad6fe74d71bbfbdd62d6ee1bbc3) (NYSE: STVN) (the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the p

    Business Wire ·

  3. Stevanato Group to Participate in Three Upcoming Investor Conferences

    Stevanato Group to Participate in Three Upcoming Investor Conferences Stevanato Group S.p.A. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.stevanatogroup.com%2Fen%2F&esheet=54528779&newsitemid=20260504199153&lan=en-US&anchor=Stevanato+Group+S.p.A.&index=1&md5=1fdbe68521c68cfdda992e35b42723a8) (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced t

    Business Wire ·

  4. Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

    Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026 Stevanato Group S.p.A. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.stevanatogroup.com%2F&esheet=54521861&newsitemid=20260423182790&lan=en-US&anchor=Stevanato+Group+S.p.A.&index=1&md5=70c2f419d7c7dc7d02b2f4280d53425f) (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announce

    Business Wire ·

  5. Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

    Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum Stevanato Group S.p.A. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.stevanatogroup.com%2Fen%2F&esheet=54447299&newsitemid=20260312286247&lan=en-US&anchor=Stevanato+Group+S.p.A.&index=1&md5=2693e4977adad12f8934d7eafccc06b8) (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industr

    Business Wire ·